Cyclo Therapeutics Analyst Ratings
Cyclo Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/27/2023 | 173.97% | Maxim Group | → $4 | Upgrades | Hold → Buy |
| 03/21/2023 | — | Maxim Group | Downgrades | Buy → Hold | |
| 12/17/2020 | 721.92% | Maxim Group | → $12 | Initiates Coverage On | → Buy |
What is the target price for Cyclo Therapeutics (CYTH)?
The latest price target for Cyclo Therapeutics (NASDAQ: CYTH) was reported by Maxim Group on September 27, 2023. The analyst firm set a price target for $4.00 expecting CYTH to rise to within 12 months (a possible 173.97% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cyclo Therapeutics (CYTH)?
The latest analyst rating for Cyclo Therapeutics (NASDAQ: CYTH) was provided by Maxim Group, and Cyclo Therapeutics upgraded their buy rating.
When is the next analyst rating going to be posted or updated for Cyclo Therapeutics (CYTH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cyclo Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cyclo Therapeutics was filed on September 27, 2023 so you should expect the next rating to be made available sometime around September 27, 2024.
Is the Analyst Rating Cyclo Therapeutics (CYTH) correct?
While ratings are subjective and will change, the latest Cyclo Therapeutics (CYTH) rating was a upgraded with a price target of $0.00 to $4.00. The current price Cyclo Therapeutics (CYTH) is trading at is $1.46, which is within the analyst's predicted range.
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/27/2023 | 173.97% | Maxim Group | → $4 | Upgrades | Hold → Buy |
| 03/21/2023 | — | Maxim Group | Downgrades | Buy → Hold | |
| 12/17/2020 | 721.92% | Maxim Group | → $12 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/27/2023 | 173.97% | Maxim集團 | →$4 | 升級 | 持有→購買 |
| 03/21/2023 | - | Maxim集團 | 評級下調 | 購買→Hold | |
| 12/17/2020 | 721.92% | Maxim集團 | →$12 | 開始承保 | →購買 |
What is the target price for Cyclo Therapeutics (CYTH)?
Cyclo Treeutics(Cyclo Treeutics)的目標價格是多少？
The latest price target for Cyclo Therapeutics (NASDAQ: CYTH) was reported by Maxim Group on September 27, 2023. The analyst firm set a price target for $4.00 expecting CYTH to rise to within 12 months (a possible 173.97% upside). 2 analyst firms have reported ratings in the last year.
梅克西姆集團於2023年9月27日報道了Cyclo治療公司(納斯達克代碼：CYTH)的最新目標價。這家分析公司將目標價定為4美元，預計CyTH將在12個月內上漲至173.97(可能上漲173.97)。去年有兩家分析公司公佈了評級。
What is the most recent analyst rating for Cyclo Therapeutics (CYTH)?
Cyclo Treeutics(CyTH)的最新分析師評級是什麼？
The latest analyst rating for Cyclo Therapeutics (NASDAQ: CYTH) was provided by Maxim Group, and Cyclo Therapeutics upgraded their buy rating.
梅克西姆集團提供了對Cyclo治療公司(納斯達克代碼：CYTH)的最新分析師評級，而Cyclo治療公司上調了其買入評級。
When is the next analyst rating going to be posted or updated for Cyclo Therapeutics (CYTH)?
Cyclo Treeutics(CyTH)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cyclo Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cyclo Therapeutics was filed on September 27, 2023 so you should expect the next rating to be made available sometime around September 27, 2024.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閱公共財務報表，與Cyclo治療公司的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Cyclo治療公司的上一次評級是在2023年9月27日提交的，所以你應該預計下一次評級將在2024年9月27日左右的某個時候提供。
Is the Analyst Rating Cyclo Therapeutics (CYTH) correct?
分析師對Cyclo Treeutics(CyTH)的評級正確嗎？
While ratings are subjective and will change, the latest Cyclo Therapeutics (CYTH) rating was a upgraded with a price target of $0.00 to $4.00. The current price Cyclo Therapeutics (CYTH) is trading at is $1.46, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Cyclo治療公司(CyTH)評級被上調，目標價從0.00美元到4.00美元。Cyclo治療公司(Cyclo Treeutics)目前的交易價格為1.46美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧